The global astringent market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The key players operating in the market focuses on offering various unique products to stay competitive in the marketplace.  Repechage offers their new seaweed-based Hydra Refine Astringent Pads for Normal to Oily Skin, which are designed to sweep away excess oils while refining pores in one easy step to create a flawless complexion. The new Hydra Refine Astringent Pads are pre-saturated with powerful natural ingredients such as hydrating and refining Laminaria Saccharina Seaweed extract, antioxidant Farnesol—an extract of Lily of the Valley, brightening Licorice Root extract, astringent and fragrant Lemongrass, soothing Aloe and Cucumber to help smooth the skin while reducing the appearance of oiliness and large pores. 

The global apoptosis receptor BAX market is anticipated to grow at a significant CAGR of 6.2% during the forecast period 2022-2028. The rising biomedical research activities is a major factor attributing to the growth of the market. For instance, according to the research paper published on BMJ Publishing Group Ltd & British Society of Gastroenterology in February 2022, the Bax/Bcl-2 system did not seem to be involved in induction of apoptosis of epithelial cells in the inflamed colonic mucosa of UC.

The global acute otitis media treatment market is anticipated to grow at a considerable CAGR during the forecast years. Acute otitis media is an ear infection caused by the eardrums. It is also called a middle ear infection. The acute otitis media infection majorly happens in children and young adults. The increasing population of young adults around the globe is the factor for increasing patients suffering from acute otitis media, increasing the demand for acute otitis media treatment. 

The global esomeprazole sodiums market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The key driving factor for global esomeprazole sodiums market growth is an increase in the number of instances of gastroesophageal reflux disease (GERD) caused by excessive stomach acid production. GERD is a disorder in which the stomach's digestive acid comes into contact with the esophagus, resulting in discomfort known as heartburn. 

The global cloxacillin market is anticipated to grow at a considerable CAGR during the forecast years due to the increasing number of bacterial infection patients. Cloxacillin is used in the treatment of acute bacterial skin and soft tissue infection. It can be administered in both ways, by mouth, and by injection for those who face problems in swallowing tablets and capsules. Cloxacillin comes under different names and forms including Myoclox CV, Klox, Mediclox, Jolclo, Aclox, and many other tablets, capsules, and injections.

The global anaplastic thyroid cancer drug market is expected to grow at a CAGR of nearly 6% during the forecast period. (2022-2028). Anaplastic thyroid carcinoma is a kind of thyroid cancer that is rare and aggressive. Thyroid cancer accounts for roughly 1-2 percent of all cancers.  In May 2018, the combination of tafinlar and mekinist has been approved for the treatment of BRAF V600E mutation-positive ATC that cannot be surgically treated or has spread to other organs. 

The global wilms tumor protein market is anticipated to grow at a considerable CAGR of 2.1% during the forecast period (2022-2028). All the major players in the global wilms tumor protein market are involved in strategic alliances like acquisitions, partnerships, and collaborations to launch new products to stay competitive in the market. Several researches are in pipeline of trial and FDA approval which will boost the global wilms tumor protein market during the forecast period. For instance, in October 2020, Sumitomo Dainippon Pharma Oncology, Inc., announced the dosing of the first patient with DSP-7888 in the Phase 2 expansion portion of the study evaluating the vaccine.

The global somatostatin receptor type market is anticipated to grow at a considerable CAGR during the forecast years. The major factor for the growth in the global somatostatin receptor type market is the new developments in the somatostatin receptor type for better treatment. For instance, in November 2021, Crentics Pharmaceuticals, Inc. announced new data for the poster presentation at the annual Society for Endocrinology BES congress. The data is collected from the ongoing open-label extension (OLE) trials. The trials are based on the effects of paltusotine in acromegaly patients. Paltusotine is a nonpeptide agonist that is highly selective for the investigation with somatostatin receptor type 2. 

The global pediatric medicines market is anticipated to grow at a significant CAGR of around 5% during the forecast years. Pediatric medicines are the branch of the healthcare industry tech deals with the treatment of various diseases in children. One of the key factors for the growth of the global pediatric medicines market is the increasing number of pediatric patients due to the increasing pediatric population around the world. Infants, children, and young adults coming under the pediatric population may suffer infections, fever, pain, and other problems that can be treated using pediatric medicine. In addition, several research and development activities in the field of pediatric medicines have also improved health care by providing improved pediatric medicines to patients. 

The Global Eyecare product market is anticipated to grow at a considerable CAGR of around 4.6% during the forecast period. Technological advancements are taking place at a fair considerable rate in the present time. This will also continue in the future as researchers and scientists in collaboration with tech companies are developing new therapies for treating eye problems. This will be a driver for the eye care product market in the future. Medicines and drugs are developed by pharma companies that help in the treatment of eye problems. For instance, in Feb 2022, Allergan which is a market player in the eye care product market announced that it will present data from companies portfolio of eye care treatment at the American Glaucoma Society annual meeting which will be held in Nashville.